2021
DOI: 10.3390/antibiotics10091097
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Cryptic Antibiotic Biosynthetic Gene Clusters Guided by RNA-seq Data from Both Streptomyces ansochromogenes and ΔwblA

Abstract: With the increase of drug resistance caused by the improper use and abuse of antibiotics, human beings are facing a global health crisis. Sequencing of Streptomyces genomes revealed the presence of an important reservoir of secondary metabolic gene clusters for previously unsuspected products with potentially valuable bioactivity. It has therefore become necessary to activate these cryptic pathways through various strategies. Here, we used RNA-seq data to perform a comparative transcriptome analysis of Strepto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 41 publications
0
5
0
Order By: Relevance
“…The corresponding BGC was identified (Fig. 3a ), and renamed as ang in this study for its high identity with angolamycin BGC 39 , 40 . To demonstrate if VRS-bAHL can facilitate the characterization of the activated secondary metabolite BGCs, an ang expression reporter strain 7100ang-cviI was constructed, in which P ang1 , the promoter of a key structural gene ang1 (also named as ctg1_1275 ), was used to drive cviI .…”
Section: Resultsmentioning
confidence: 99%
“…The corresponding BGC was identified (Fig. 3a ), and renamed as ang in this study for its high identity with angolamycin BGC 39 , 40 . To demonstrate if VRS-bAHL can facilitate the characterization of the activated secondary metabolite BGCs, an ang expression reporter strain 7100ang-cviI was constructed, in which P ang1 , the promoter of a key structural gene ang1 (also named as ctg1_1275 ), was used to drive cviI .…”
Section: Resultsmentioning
confidence: 99%
“…There is an urgent need to cope with the antibiotic crisis and resistant pathogens, especially those with cross-resistance to multiple drugs. Mining of genomes with multi-omics techniques and rational modification of compounds are quick approaches for expanding the capacity of bioactive products libraries [ 20 ]. Uridyl peptide compounds are emerging as a new family of drug leads for their unique activities specifically against the Gram-negative bacteria Pseudomonas ; hence, they hold great potential in clinical applications.…”
Section: Discussionmentioning
confidence: 99%
“…3A). 32 The comparative analysis of RNA-seq data revealed that the disruption of wblA abolished the biosynthesis of nikkomycin, acarbose, and validamycin while activating the biosynthesis of tylosin analog, porphyrin, and chlorophyll. The RNA-seq data also identified that the regulatory gene rsbR is positively regulated by WblA.…”
Section: Transcriptional Analysis Of Natural Product Biosynthetic Gen...mentioning
confidence: 99%